AACR: A 'tissue agnostic' indication for Retevmo? Lilly says it's possible with RET cancer win

10th April 2021 Uncategorised 0

AACR: A ’tissue agnostic’ indication for Retevmo? Lilly says it’s possible with RET cancer win
aliu
Sat, 04/10/2021 – 10:04

More: AACR: A 'tissue agnostic' indication for Retevmo? Lilly says it's possible with RET cancer win
Source: fierce